Therefore, AURKA, PRC1, TOP2A, AOX1, CYP2E1, and CYP3A4 can be considered candidate liver-biopsy markers for high risk of developing HCC and poor prognosis in HCC. This evidence concerns the gene AOX1 and hepatocellular carcinoma.